EUVIMEDEUVIMED entdecken
Open Access

Development of a Pregnancy Cohort in Commercial Insurance Claims Data: Evaluation of Deliveries Identified From Inpatient Versus Outpatient Claims

Jacob C Kahrs iD, Katelin B Nickel iD, Mollie E Wood iD, Sascha Dublin iD, Michael J Durkin iD, Sarah S Osmundson iD, Dustin Stwalley iD, Elizabeth A Suarez iD, Anne M Butler iD

Pharmacoepidemiology and Drug Safety · 2025

DOI: 10.1002/pds.70115 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacoepidemiology and Drug Safety, 2025. Verfasst von Jacob C Kahrs und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. Hauptthemen laut MEDLINE: Delivery, Obstetric, Insurance Claim Review, Outpatients, Inpatients. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Astellas, Boehringer Ingelheim, National Institute of Child Health and Human Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Studies using insurance claims data to identify pregnancies are rarely able to directly assess the validity of the pregnancy/delivery. Inpatient versus outpatient delivery claims may provide different levels of evidence, but more stringent requirements could result in exclusion of true pregnancies. We identified delivery codes from the inpatient and outpatient settings and examined possible confirmatory evidence suggesting that a delivery truly occurred.

Methods

Using a US commercial insurance database (2006–2021), we identified potential pregnancies by presence of delivery claims from a provider and/or facility. We classified deliveries as inpatient (claim date during inpatient admission) or outpatient (claim date not during inpatient admission). We identified possible confirmatory evidence for each delivery including: (1) Presence of both provider and facility delivery codes; (2) presence of both diagnosis and procedure delivery codes; (3) labor and delivery revenue codes; (4) gestational age diagnosis codes; (5) pregnancy‐related care codes; (6) linkage to an infant claim; and (7) infant insurance enrollment and linkage to a birthing parent. We quantified the proportion of deliveries with confirmatory evidence by delivery setting. Among deliveries with ≥ 1 piece of confirmatory evidence, we compared patient characteristics by apparent delivery setting.

Results

Among 4 084 474 delivery episodes, 96.4% were classified as inpatient and 3.6% outpatient. 99.9% of inpatient and 94.0% of outpatient deliveries had ≥ 1 piece of confirmatory evidence. Pregnancy‐related care codes were the most common type of confirmatory evidence (99.0% inpatient, 85.7% outpatient). Deliveries classified as inpatient occurred among patients who were older and more clinically complex (i.e., more pregnancy complications, chronic diseases, and prescription medications).

Conclusions

The vast majority of deliveries had confirmatory evidence regardless of apparent setting. Patient characteristics differed by delivery setting. Inclusion of apparent outpatient deliveries may increase the sample size of the study population and improve the generalizability of study results.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Delivery, ObstetricInsurance Claim ReviewOutpatientsInpatientsHumansFemalePregnancyDatabases, FactualUnited StatesAdultCohort StudiesYoung AdultInsurance, HealthHospitalization

Stichwörter der Autor:innen

administrative datahealthcare claimspharmacoepidemiologypregnancy

Autor:innen und Institutionen

  • Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Department of Medicine, Division of Infectious Diseases, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Kaiser Permanente Washington Health Research Institute, Seattle, Washington, DC, USA.
  • Department of Epidemiology, University of Washington, Seattle, Washington, DC, USA.
  • Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Center for Pharmacoepidemiology and Treatment Science, Rutgers Institute for Health, Health Care Policy and Aging Research, New Brunswick, New Jersey, USA.

ORCID-Profile: Jacob C Kahrs, Katelin B Nickel, Mollie E Wood, Sascha Dublin, Michael J Durkin, Sarah S Osmundson, Dustin Stwalley, Elizabeth A Suarez, Anne M Butler

Förderung

  • Astellas
  • Boehringer Ingelheim
  • National Institute of Child Health and Human Development
  • AbbVie
  • Sarepta
  • NICHD NIH HHS
  • NCATS NIH HHS
  • GSK

Zitieren

APA

Kahrs, J. C., Nickel, K. B., Wood, M. E., Dublin, S., Durkin, M. J., Osmundson, S. S., Stwalley, D., Suarez, E. A., & Butler, A. M. (2025). Development of a Pregnancy Cohort in Commercial Insurance Claims Data: Evaluation of Deliveries Identified From Inpatient Versus Outpatient Claims. Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.70115

Vancouver

Kahrs JC, Nickel KB, Wood ME, Dublin S, Durkin MJ, Osmundson SS, et al. Development of a Pregnancy Cohort in Commercial Insurance Claims Data: Evaluation of Deliveries Identified From Inpatient Versus Outpatient Claims. Pharmacoepidemiology and Drug Safety. 2025. doi:10.1002/pds.70115

BibTeX
@article{Kahrs2025,
  author = {Kahrs, Jacob C and Nickel, Katelin B and Wood, Mollie E and Dublin, Sascha and Durkin, Michael J and Osmundson, Sarah S and Stwalley, Dustin and Suarez, Elizabeth A and Butler, Anne M},
  title = {Development of a Pregnancy Cohort in Commercial Insurance Claims Data: Evaluation of Deliveries Identified From Inpatient Versus Outpatient Claims},
  journal = {Pharmacoepidemiology and Drug Safety},
  year = {2025},
  doi = {10.1002/pds.70115}
}
Kostenlos starten →